DUBLIN–(BUSINESS WIRE)–The “Cell Separation Market Size, Share & Trends Analysis Report By Cell Type (Human Cells, Animal Cells), By Product (Consumables, Instruments), By Technique, By Application, By End-use, By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering.
The global cell separation market size is expected to reach USD 9.05 billion by 2030, registering a CAGR of 9.82%.
The increasing demand for biopharmaceuticals, such as recombinant therapeutic proteins, is anticipated to boost market growth. The key players focus on the development & commercialization of advanced products to cater to the needs of researchers and healthcare professionals, which is projected to drive the demand for cell isolation products in the near future.
The usage of cellular therapies is increasing for the treatment of prominent diseases, including neurological diseases, such as amyotrophic lateral sclerosis, Parkinson’s disease, spinal cord injury, and renal, skeletal, & autoimmune diseases, such as multiple sclerosis, type 1 diabetes, & Crohn’s disease.
In recent years, there has been an increase in funding from government organizations for cell-based research owing to its ability to treat & manage conditions, such as cancer and other chronic diseases. The global market witnessed an upward momentum during the pandemic.
For instance, in 2020, Seattle Children’s Research Institute’s researchers used immunoprecipitation, identified by flow cytometry (IP-FCM) test, to study the immune response of COVID-19-infected patients. As per the experiment, blood samples were collected from 24 COVID-19-positive patients to compare with blood samples of 30 healthy individuals, and the compared samples were run through the IP-FCM test.
Furthermore, increasing investments and government funding have helped boost the availability of technologically advanced processes for cell isolation & biopharmaceutical production. These advancements have resulted in an increased demand for cell separation procedures, thus propelling the market growth.
Cell Separation Market Report Highlights
- The consumables product type segment held a major revenue share of 62.87% in 2022. The increasing investments in R&D by biopharmaceutical and biotech companies are a major factor propelling the segment growth
- The biomolecule isolation application segment held the largest share of 31.3% in 2022 since it is a pivotal step in research on cancer, HIV, and other autoimmune diseases
- The human cell type segment is anticipated to have a significant growth rate of 20.8% during the forecast period. The fast growth is due to the rising focus on human and cancer stem cell research and varied applications of isolated human cells
- The centrifugation technique type segment held the highest market share of 42.7% in 2022. The availability of various centrifuges provides technicians with a wide range of options catering to their specific needs
- North America dominated the global market with a revenue share of 37.7% in 2022 owing to increasing demand for new technologies, a large pool of key players, increasing development of vaccines and therapeutics, along with advanced healthcare infrastructure
Market Dynamics
Market driver analysis
- Rising demand for biopharmaceuticals
- Increasing government funding for cell-based research
- Growing focus on personalized medicine
Market Restraint Analysis
- High cost of cell isolation products
Market Opportunities Analysis
- Growth in biopharmaceutical outsourcing industry
- Developing countries provide untapped markets for multinational players
Market Challenges Analysis
- Stringent Regulatory Frameworks and Time-Consuming Approval Processes for Cell Isolation/Separation
Cell Separation Market Analysis Tools
- SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
- Porter’s Five Forces Analysis
- COVID-19 Impact Analysis
Company Profiles
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- BD
- Terumo Corporation
- Danaher
- STEMCELL Technologies Inc.
- Bio-Rad Laboratories, Inc.
- Corning Incorporated
- Miltenyi Biotec
- GenScript
Product Business Analysis
- Cell Separation Market: Product Movement Analysis
- Consumables
- Reagents, kits, media, and sera
- Beads
- Disposables
- Instruments
- Centrifuges
- Flow cytometers
- Filtration systems
- Magnetic-activated cell separator systems
Cell Type Business Analysis
- Human Cells
- Animal Cells
Technique Business Analysis
- Centrifugation
- Surface Marker
- Filtration
Application Business Analysis
- Cell Separation Market: Application Movement Analysis
- Biomolecule Isolation
- Cancer Research
- Stem Cell Research
- Tissue Regeneration
- In vitro Diagnostics
- Therapeutics
End Use Business Analysis
- Research Laboratories and Institutes
- Biotechnology and Biopharmaceutical Companies
- Hospitals and Diagnostic Laboratories
- Cell Banks
For more information about this report visit https://www.researchandmarkets.com/r/eimlp4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900